DK1489090T3 - Hidtil ukendte pseudoerythromycinderivater - Google Patents

Hidtil ukendte pseudoerythromycinderivater

Info

Publication number
DK1489090T3
DK1489090T3 DK04022619T DK04022619T DK1489090T3 DK 1489090 T3 DK1489090 T3 DK 1489090T3 DK 04022619 T DK04022619 T DK 04022619T DK 04022619 T DK04022619 T DK 04022619T DK 1489090 T3 DK1489090 T3 DK 1489090T3
Authority
DK
Denmark
Prior art keywords
hitherto unknown
derivatives
pseudoerythromycin
pseudoerythromycin derivatives
psedoerythromycin
Prior art date
Application number
DK04022619T
Other languages
English (en)
Inventor
Satoshi Omura
Yuzuru Iwai
Toshiaki Sunazuka
Tohru Nagamitsu
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of DK1489090T3 publication Critical patent/DK1489090T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04022619T 2000-08-17 2000-08-17 Hidtil ukendte pseudoerythromycinderivater DK1489090T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00953461A EP1256587B1 (en) 2000-08-17 2000-08-17 Novel pseudoerythromycin derivatives
PCT/JP2000/005503 WO2002014338A1 (fr) 2000-08-17 2000-08-17 Nouveaux derives de pseudoerythromycine

Publications (1)

Publication Number Publication Date
DK1489090T3 true DK1489090T3 (da) 2006-05-22

Family

ID=11736361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04022619T DK1489090T3 (da) 2000-08-17 2000-08-17 Hidtil ukendte pseudoerythromycinderivater

Country Status (11)

Country Link
US (1) US6734292B1 (da)
EP (2) EP1489090B1 (da)
KR (6) KR20040066185A (da)
AT (2) ATE321770T1 (da)
AU (1) AU2000265939A1 (da)
CA (1) CA2386828C (da)
DE (2) DE60027015T2 (da)
DK (1) DK1489090T3 (da)
ES (2) ES2257720T3 (da)
PT (1) PT1489090E (da)
WO (1) WO2002014338A1 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
SI1478358T1 (sl) 2002-02-11 2013-09-30 Bayer Healthcare Llc Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
JP2003327536A (ja) * 2002-03-07 2003-11-19 Kitasato Inst:The ヒト免疫不全症候群ウイルスの感染、増殖抑制剤
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
EP1636585B2 (en) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
EP1663978B1 (en) 2003-07-23 2007-11-28 Bayer Pharmaceuticals Corporation Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
US7229972B2 (en) * 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) * 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
CN101326192B (zh) 2005-10-14 2012-06-20 社团法人北里研究所 新型二氢伪红霉素衍生物
US7407942B2 (en) * 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8084443B2 (en) 2007-10-01 2011-12-27 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
JP5733601B2 (ja) * 2010-07-13 2015-06-10 国立大学法人 千葉大学 劇症型炎症の予防および／または治療剤
EP3494989B1 (en) 2012-01-26 2025-07-16 Longhorn Vaccines and Diagnostics, LLC Composite antigenic sequences and vaccines
EP3294448A4 (en) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Rapid methods for the extraction of nucleic acids from biological samples
MX2024002892A (es) * 2021-09-07 2024-04-05 Zoetis Services Llc Azalidos inmunomoduladores.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1321581C (en) 1987-05-26 1993-08-24 Herbert A. Kirst Ring-contracted macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
US5523418A (en) 1991-04-09 1996-06-04 Abbott Laboratories Macrocyclic lactam prokinetic agents
DK0579770T3 (da) * 1991-04-09 1996-11-04 Abbott Lab Makrocycliske lactamprokinetika
DE4200145A1 (de) 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE19644195A1 (de) 1996-10-24 1998-04-30 Solvay Pharm Gmbh 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19805822B4 (de) 1998-02-13 2009-02-05 Solvay Pharmaceuticals Gmbh 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
AU2000265939A1 (en) 2002-02-25
ES2257720T3 (es) 2006-08-01
EP1256587A1 (en) 2002-11-13
KR20040066185A (ko) 2004-07-23
KR20040074096A (ko) 2004-08-21
DE60027015D1 (en) 2006-05-18
CA2386828C (en) 2006-01-24
EP1489090B1 (en) 2006-02-01
DE60025856T2 (de) 2006-10-19
KR20040066187A (ko) 2004-07-23
ATE316977T1 (de) 2006-02-15
KR20040066186A (ko) 2004-07-23
EP1256587B1 (en) 2006-03-29
ES2261224T3 (es) 2006-11-16
CA2386828A1 (en) 2002-02-21
KR20040066188A (ko) 2004-07-23
PT1489090E (pt) 2006-05-31
WO2002014338A1 (fr) 2002-02-21
DE60027015T2 (de) 2006-10-05
US6734292B1 (en) 2004-05-11
EP1256587A4 (en) 2004-01-28
KR20040066184A (ko) 2004-07-23
EP1489090A1 (en) 2004-12-22
DE60025856D1 (de) 2006-04-13
ATE321770T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
DK1489090T3 (da) Hidtil ukendte pseudoerythromycinderivater
ECSP045294A (es) Derivados de 2,4-diaminopirimidina
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
UY26551A1 (es) " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas".
HRP20080664A2 (hr) Supstituirani piridinski herbicidi
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BR9900177A (pt) Inibidores de metaloprotease.
DE60042762D1 (de) Zwischenprodukte für die Herstellung von Harnstoffderivaten mit Muskarinrezeptor-antagonistischer Aktivität
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
CY1123488T1 (el) Πεντακυκλοθειενυλο και ινδανυλο παραγωγα ουριας ως παραγοντες διανοιξης διαυλου καλιου
UY27338A1 (es) Nuevos derivados de ácido sulfónico
MA27046A1 (fr) Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens.
ATE278661T1 (de) Anthranilsäurederivate
EP1671957A4 (en) THIADIAZOLINDERIVATE
DK1454903T3 (da) Thiadiazolinderivater til behandling af cancer
CO5680420A2 (es) Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4
BRPI0408675A (pt) derivados de talidomida solúveis em água
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
DE60017374D1 (de) Antibakterielle mittel
EA200200838A1 (ru) N-(гетероциклил)бензол- или пиридинсульфонамиды в качестве антитромботических агентов и антикоагулянтов
DK1338596T3 (da) Fremgangsmåde til fremstilling af antibakterielt middel af carbapenemtypen
ES2159489A1 (es) Nuevos derivados de imidazol con actividad antiinflamatoria.
BR0113978A (pt) Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas
BR0110328A (pt) Compostos heterocìclicos com atividade antiinflamatória